The indicator test neuropad in the assessment of small and overall nerve fibre dysfunction in patients with type 2 diabetes: A large multicentre study

Experimental and Clinical Endocrinology and Diabetes

Volumn 122, Issue 3, 2014, Pages 195-199

  Manes, C ^a   Papanas, N ^b   Exiara, T ^a   Katsiki, N ^c   Papantoniou, S ^d   Kirlaki, E ^e   Tsotoulidis, S ^f   Kefalogiannis, N ^e   Maltezos, E ^b  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d General Hospital of Kavala   (Greece)

^e Venizelion General Hospital   (Greece)

^f Health Centre   (Greece)

Author keywords

diabetes mellitus; diabetic neuropathy; Neuropad; small fibre dysfunction; sudomotor dysfunction.

Indexed keywords

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROLOGIC EXAMINATION; NEUROPAD; NEUROPATHY; NEUROPATHY DISABILITY SCORE; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERALL NERVE FIBER DYSFUNCTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; SMALL NERVE FIBRE DYSFUNCTION; SWEATING; AGED; AGING; CLINICAL TRIAL; COMPLICATION; DEVICES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; EVALUATION STUDY; GREECE; MIDDLE AGED; NERVE FIBER; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY;

AGED; AGING; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; NEUROLOGIC EXAMINATION; REPRODUCIBILITY OF RESULTS; SWEATING;

EID: 84896448700     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1367061     Document Type: Article

References (44)

1. American Diabetes Association Standards of medical care in diabetes - 2013. Diabetes Care: 2013; 36 01 S11 S66
2. Abbott C. A., Vileikyte L., Williamson S. et al. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care: 1998; 21 1071 1075 (Pubitemid 28368510)
3. Abbott C. A., Carrington A. L., Ashe H. et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med: 2002; 19 377 384 (Pubitemid 34534212)
4. Antonoglou C., Papanas N., Maltezos E. Lipid-lowering therapy in the diabetic foot: seeing the whole iceberg and not just the tip. Curr Vasc Pharmacol: 2012; [Epub ahead of print]
5. Apelqvist J., Bakker K., van Houtum W. H. et al. International Working Group on the Diabetic Foot (IWGDF) Editorial Board Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev: 2008; 24 01 S181 S187
6. Bierhaus A., Nawroth P. P. Critical evaluation of mouse models used to study pain and loss of pain perception in diabetic neuropathy. Exp Clin Endocrinol Diabetes: 2012; 120 188 190
7. Boulton AJ M., Kirsner R. S., Vileikyte L. Neuropathic diabetic foot ulcers. N Engl J Med: 2004; 351 48 55
8. th Camillo Golgi lecture. Diabetologia: 2004; 47 1343 1353 (Pubitemid 39232418)
9. Calvet J. H., Dupin J., Winiecki H. et al. Assessment of small fiber neuropathy through a quick, simple and non invasive method in a German diabetes outpatient clinic. Exp Clin Endocrinol Diabetes: 2013; 121 80 83
10. Chin M. H., Auerbach S. B., Cook S. et al. Quality of diabetes care in community health centers. Am J Public Health: 2000; 90 431 434 (Pubitemid 30115423)
11. De Berardis G., Pellegrini F., Franciosi M. et al. The QuED Study Group-Quality of Care and Outcomes in Type 2 Diabetes. J Diabet Complications: 2005; 19 319 327
12. Eaton S., Tesfaye S. Clinical manifestations and measurement of neuropathy. Diabetes Rev: 1999; 7 312 325
13. Forsblom C. M., Sane T., Groop P. H. et al. Risk factors for mortality in type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia: 1998; 4 1253 1262 (Pubitemid 28488750)
14. Kamenov Z. A., Petrova J. J., Christov V. G. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (Neuropad) tests in the clinical practice. Exp Clin Endocrinol Diabetes: 2010; 118 226 233
15. Liatis S., Marinou K., Tentolouris N. et al. Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabet Med: 2007; 24 1375 1380 (Pubitemid 350179435)
16. Low V. A., Sandroni P., Fealey R. D. et al. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve: 2006; 34 57 61
17. Manes C., Papazoglou N., Sossidou E. et al. Prevalence of diabetic neuropathy and foot ulceration identification of potential risk factors - A population based study. Wounds: 2002; 14 11 15 (Pubitemid 41510715)
18. Martina IS J., van Koningsveld R., Schmitz PI M. et al. Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. J Neurol Neurosurg Psychiatry: 1998; 65 743 747 (Pubitemid 28486656)
19. Mondelli M., Aretini A., Baldasseroni A. Distal symmetric polyneuropathy in diabetes. Differences between patients with and without neuropathic pain. Exp Clin Endocrinol Diabetes: 2012; 120 45 50
20. Papanas N., Papatheodorou K., Christakidis D. et al. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes: 2005; 113 195 198 (Pubitemid 40695323)
21. Papanas N., Papatheodorou K., Papazoglou D. et al. Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication. Exp Clin Endocrinol Diabetes: 2005; 113 577 581 (Pubitemid 41810501)
22. Papanas N., Papatheodorou K., Papazoglou D. et al. The new indicator test (Neuropad): a valuable diagnostic tool for small-fiber impairment in patients with type 2 diabetes. Diabetes Educ: 2007; 33 257 262
23. Papanas N., Giassakis G., Papatheodorou K. et al. Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes: 2007; 115 58 61 (Pubitemid 46293415)
24. Papanas N., Papatheodorou K., Papazoglou D. et al. An insertion/deletion polymorphism in the alpha2B adrenoceptor gene is associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes: 2007; 115 327 330 (Pubitemid 46877867)
25. Papanas N., Maltezos E. The diabetic foot: established and emerging treatments. Acta Clin Belg: 2007; 62 230 238 (Pubitemid 47234752)
26. Papanas N., Papatheodorou K., Papazoglou D. et al. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes: 2008; 116 135 138 (Pubitemid 351363386)
27. ® for the early diagnosis of peripheral neuropathy in type 2 diabetes. Exp Clin Endocrinol Diabetes: 2011; 119 122 125
28. Papanas N., Paschos P., Papazoglou D. et al. Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes. Diabetes Care: 2011; 34 1378 1382
29. Papanas N., Maltezos E., Edmonds M. Salvation of the diabetic foot: still a quest for the Holy Grail? Vasa: 2011; 40 267 269
30. Papanas N., Katsiki N., Papatheodorou K. et al. Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus. Angiology: 2011; 62 291 295
31. Papanas N., Ziegler D. New diagnostic tests for diabetic distal symmetric polyneuropathy. J Diabetes Complications: 2011; 25 44 51
32. Papanas N., Boulton A. J., Malik R. A. et al. A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet Med: 2013; 30 525 534
33. Quattrini C., Jeziorska M., Malik R. Small fiber neuropathy in diabetes: clinical consequences and assessment. Int J Low Extrem Wounds: 2004; 3 16 21
34. Quattrini C., Jeziorska M., Tavakoli M. et al. The Neuropad test: a visual indicator test for human diabetic neuropathy. Diabetologia: 2008; 51 1046 1050
35. Shaw J. E., Zimmet P. Z., Gries F. A. et al. Epidemiology of diabetic neuropathy. In: Gries F. A., Cameron N. E., Low P. A., Ziegler D. (Eds.). Textbook of Diabetic Neuropathy. Stuttgart Thieme Verlag: 2003; 64 82
36. Spallone V., Morganti R., Siampli M. et al. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabet Med: 2009; 26 686 692
37. Tentolouris N., Achtsidis V., Marinou K. et al. Evaluation of the self-administered indicator plaster Neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care: 2008; 31 236 237 (Pubitemid 351213327)
38. Tesfaye S., Boulton A. J., Dyck P. J. et al. Toronto Diabetic Neuropathy Expert Group Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care: 2010; 33 2285 2293
39. Várkonyi T., Putz Z., Keresztes K. et al. Current options and perspectives in the treatment of diabetic neuropathy. Curr Pharm Des: 2013; 19 4981 5007
40. Veves A., Young M. J., Manes C. et al. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: a clinical study. Diabetes Care: 1994; 17 1200 1202 (Pubitemid 24307459)
41. Vinik A. I., Erbas T., Stansberry K. B. et al. Small fiber neuropathy and neurovascular disturbances in diabetes mellitus. Exp Clin Endocrinol Diabetes: 2001; 109 02 S451 S473 (Pubitemid 32577595)
42. Young M. J., Boulton AJ M., Macleod A. F. et al. A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia: 1993; 36 150 154 (Pubitemid 23034314)
43. Ziegler D., Papanas N., Roden M. GDC Study Group Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes. Diabet Med: 2011; 28 1412 1415
44. Ziegler D., Papanas N., Rathmann W. et al. KORA Study Group Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey. Diabetes Metab Res Rev: 2012; 28 692 697